AFP and cancer: Some recombinant fragment proteins of AFP domain3 have been reported, such as rAFP3D, which has residues 404–6098; r3dAFP, which has residues 357–5907; and AFP‐3 BC, which has residues 473–596,6 these fragments can deliver drugs to destroy cancer cells.